Radiographic regression of cranial meningioma in a NF2 patient treated by bevacizumab

Affiliations

• ¹ Department of Neurosurgery, Neurofibromatosis type 2 Clinic of Ile de France Neurofibromatosis Reference Centre, Hôpital Beaujon, Assistance Publique Hôpitaux de Paris; INSERM U674; Faculty of Medicine, Université Paris 7 - Denis Diderot.
• ² Faculty of Medicine, Université Paris 7 - Denis Diderot; Inter-Hospital Oncology Service, Hôpital Beaujon and Institut National de la Santé et de la Recherche Médicale, Assistance Publique Hôpitaux de Paris.
• ³ Faculty of Medicine, Université Paris 7 - Denis Diderot; Department of ENT.
• ⁴ Department of Radiology, Hôpital Beaujon, Assistance Publique Hôpitaux de Paris, Paris, France.
• ⁵ Department of Neurosurgery, Neurofibromatosis type 2 Clinic of Ile de France Neurofibromatosis Reference Centre, Hôpital Beaujon, Assistance Publique Hôpitaux de Paris; INSERM U674; Faculty of Medicine, Université Paris 7 - Denis Diderot. Electronic address: michel.kalamarides@bjn.aphp.fr.